Increased levels of syndecan-3 are associated with childhood obesity
Loading...
Identifiers
Publication date
Advisors
Tutors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
CellPress
Abstract
Childhood obesity is considered an important risk factor for developing obesity in adult. Syndecan-3 (SDC3) has recently come into focus as a possible molecular target involved in alterations of energy homeostasis, however, its role in childhood obesity remains undefined. We measured mRNA expression levels of SDC3 in children and adolescents with obesity from peripheral blood mononuclear cells and correlating them with different anthropometric and biochemical parameters. We performed a cross-sectional study involving 143 Caucasian children and adolescents. We found increased SDC3 expression in children and adolescents with obesity. In addition, a positive statistical correlation has been found between the levels of SDC3 with body weight, BMI, BMI Z score, fat mass, waist circumference, insulin levels, HOMA-IR index, and maximum blood pressure. Finally, a multiple linear regression analysis indicated that the BMI Z score variable was the most significant. Taken together, our results highlight a still unexplored link between SDC3 and childhood obesity
Description
Keywords
Bibliographic citation
Muñoz-Moreno, D., Prida, E., Baumann, A. Y., Pérez-Lois, R., Bascoy, M., Dopico, L. D., Brea-García, B., Villalón, M., Picans-Leis, R., Vázquez-Cobela, R., Estany-Gestal, A., Seoane, L. M., Leis, R., Al-Massadi, O., & Quiñones, M. (2025). Increased levels of syndecan-3 are associated with childhood obesity. iScience, 28(8), 113111. https://doi.org/10.1016/j.isci.2025.113111
Relation
Has part
Has version
Is based on
Is part of
Is referenced by
Is version of
Requires
Publisher version
https://doi.org/10.1016/j.isci.2025.113111Sponsors
This study has been funded by Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación and co-funded by the FEDER Program of European Union (FEDER) (M.Q.: PID2022-142084OA-100). Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union (R.L.: PI20/00924; L.M.S.: PI22/00202 and O.A.-M.: PI21/01216 and PI24/00916). GAIN-XUNTA Galicia Proyectos de Excelencia (M.Q.: IN607D 2023/02; O.A.-M.: IN607D-2022-07; L.M.S.: IN607D-2022-04). Fundación de la Sociedad Gallega de Endocrinología y Nutrición (M.Q.:2023) and (O.A.-M.:2022). Centro de Investigación Biomédica en Red (CIBER) de Fisiopatología de la Obesidad y Nutrición (CIBERobn). CIBERobn is an initiative of the ISCIII of Spain, which is supported by FEDER funds. D.M.-M., E.P., and R.P.-Lois hold a IDIS fellowship. M.B. is a recipient of a predoctoral contract PFIS funded by the ISCIII (FI23/00256). M.Q. and O.A.-M. were funded by a research contract Miguel Servet (CP21/00108 and CP20/00146, respectively) from the ISCIII
Rights
© 2025 The Author(s). Published by Elsevier Inc. This article is available under the Creative Commons CC-BY-NC-ND license
Attribution-NonCommercial-NoDerivatives 4.0 International
Attribution-NonCommercial-NoDerivatives 4.0 International



